Patient Blood Management (PBM) is an evidence-based, multidisciplinary approach that focuses on optimizing a patient’s own blood before, during, and after surgery. Rather than relying on blood transfusions as the primary treatment for perioperative blood loss, PBM emphasizes preventing anemia, minimizing surgical bleeding, and improving the body’s ability to tolerate lower hemoglobin levels when clinically appropriate. Over the past decade, PBM has become a global standard of care, with leading healthcare organizations recommending its implementation across surgical specialties to improve patient safety and preserve valuable blood resources.

Every year, hundreds of millions of surgical procedures are performed worldwide, and a significant proportion of patients experience anemia or require blood transfusions. While blood transfusion can be life-saving, it is also associated with potential risks such as transfusion reactions, infections, transfusion-associated circulatory overload (TACO), transfusion-related acute lung injury (TRALI), immunomodulation, and increased healthcare costs. Studies consistently show that unnecessary transfusions may prolong hospital stays and increase postoperative complications.

PBM shifts the focus from treating blood loss with donated blood to preserving the patient’s own blood, resulting in improved recovery, fewer complications, reduced intensive care admissions, and better long-term outcomes.

The first pillar involves identifying and treating anemia several weeks before elective surgery. Preoperative anemia is one of the strongest predictors of postoperative complications and blood transfusion requirements. Ideally, patients should undergo a complete blood count (CBC), iron studies, vitamin B12, folate levels, and renal function assessment 4–8 weeks before surgery.

Iron deficiency remains the leading cause of preoperative anemia. Oral iron therapy may be appropriate for mild anemia when surgery is several weeks away, while intravenous iron is preferred for moderate to severe iron deficiency or when surgery is imminent. Selected patients with chronic kidney disease or anemia of chronic disease may also benefit from erythropoiesis-stimulating agents under specialist supervision.

Reducing surgical bleeding is central to successful PBM. Surgeons and anesthesiologists work together to employ meticulous surgical techniques, minimally invasive procedures where appropriate, careful hemostasis, controlled blood pressure, maintenance of normal body temperature, and the use of topical hemostatic agents.

Tranexamic acid (TXA), an antifibrinolytic medication, has become a cornerstone of modern blood conservation. A common adult regimen is 1 g intravenously before incision, with an additional 1 g during prolonged procedures when indicated, although dosing should follow institutional protocols and patient-specific factors.

Other blood conservation techniques include intraoperative cell salvage, acute normo-volemic hemodilution, point-of-care coagulation monitoring using thromboelastography (TEG) or rotational thromboelastometry (ROTEM), and goal-directed transfusion strategies.

Postoperative PBM focuses on preventing unnecessary blood sampling, identifying ongoing bleeding early, correcting nutritional deficiencies, encouraging early mobilization, and maintaining adequate oxygen delivery. Current evidence supports a restrictive transfusion strategy for most stable surgical patients, with transfusion often considered when hemoglobin falls below 7–8 g/dL, while recognizing that thresholds should be individualized based on symptoms, cardiovascular disease, active bleeding, and overall clinical status.

Successful PBM combines multiple interventions throughout the perioperative period:

  • Early diagnosis and treatment of anemia
  • Iron supplementation when indicated
  • Careful surgical hemostasis
  • Minimally invasive surgical techniques
  • Tranexamic acid administration
  • Cell salvage during major blood loss procedures
  • Restrictive transfusion thresholds
  • Point-of-care coagulation testing
  • Early postoperative rehabilitation

These strategies significantly reduce exposure to allogeneic blood transfusion while maintaining patient safety.

Hospitals that implement comprehensive PBM programs consistently report substantial clinical and economic benefits. These include lower transfusion rates, fewer postoperative infections, decreased intensive care utilization, shorter hospital stays, reduced healthcare costs, and improved patient satisfaction. PBM also supports national blood supply sustainability by reducing unnecessary demand for donated blood.

Patient Blood Management is now widely incorporated into major surgical disciplines:

  • Cardiac surgery: Cell salvage, antifibrinolytic therapy, and coagulation-guided transfusion reduce bleeding and reoperation rates.
  • Orthopedic surgery: Routine TXA use in joint replacement significantly decreases blood loss and transfusion requirements.
  • Trauma surgery: Early hemorrhage control, balanced resuscitation, and massive transfusion protocols improve survival.
  • Obstetric surgery: PBM plays a critical role in managing postpartum hemorrhage through rapid bleeding control and targeted transfusion.
  • Cancer surgery: Preoperative anemia correction improves treatment tolerance and postoperative recovery.
  • Pediatric surgery: Blood conservation is particularly important because children have much smaller circulating blood volumes.

Several simple calculations support peri-operative blood management.

  • Adult male: 70 mL/kg
  • Adult female: 65 mL/kg
  • Children: 75–80 mL/kg

Example:
A 70-kg male has an estimated blood volume of:

70 × 70 = 4,900 mL

Allowable Blood Loss (ABL):

ABL = EBV × (Starting Hb − Target Hb) ÷ Starting Hb

Example:

  • EBV = 4,900 mL
  • Starting Hb = 14 g/dL
  • Target Hb = 8 g/dL

ABL = 4,900 × (14 − 8) ÷ 14

ABL ≈ 2,100 mL

These calculations help surgical teams anticipate transfusion needs and plan blood conservation strategies.

Recent international guidance emphasizes that PBM should be integrated into routine surgical care rather than reserved for complex procedures. Hospitals are increasingly adopting electronic transfusion stewardship programs, standardized anemia screening pathways, multidisciplinary PBM teams, and real-time monitoring of transfusion practices. Advances in artificial intelligence are also beginning to assist clinicians by predicting bleeding risk and supporting evidence-based transfusion decisions.

Patient Blood Management represents a major advancement in perio-perative medicine. By focusing on the patient’s own blood, PBM improves surgical outcomes while reducing reliance on donated blood. Modern PBM combines early anemia management, meticulous surgical techniques, evidence-based transfusion practices, and multidisciplinary collaboration to deliver safer, more efficient surgical care.

As healthcare systems continue to adopt PBM principles, patients can expect fewer transfusions, lower complication rates, faster recovery, and better overall outcomes. For surgeons, anesthesiologists, and healthcare institutions alike, Patient Blood Management is no longer simply an option—it has become an essential component of high-quality, patient-centered surgical practice.